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Developmental neurobiologists have made great progress 
in elucidating the molecular mechanisms underlying 
nervous system development. Th   ere has been less focus, 
however, on the consequences when these processes go 
wrong. As the evidence increases that mutations in neuro-
developmental genes are associated with major psychi-
atric disorders, deﬁ  ning these consequences assumes para-
mount importance in elucidating pathogenic mechanisms.
The convergence of psychiatry and developmental 
neurobiology
Mutations in many diﬀ  erent genes controlling cell migra-
tion, axon guidance and especially synaptogenesis are 
being found at an increasing rate in patients with schizo-
phrenia, autism, epilepsy, mental retardation and other 
disorders [1]. Th  ese discoveries are prompting a para-
digm shift regarding models of the genetic architecture of 
these disorders, which can be seen to be highly hetero-
geneous and primarily due to rare mutations in any of a 
large number of diﬀ  erent loci [2]. Th   ey also indicate that 
these distinct clinical categories share over  lapping 
etiologies and strongly implicate neuro  develop  mental 
processes in a signiﬁ  cant proportion of cases.
In this context, investigating the  genetics of neuro-
development in animals assumes greater importance. 
Many researchers have used genetic approaches in model 
organisms to dissect how neurodevelopmental processes 
work - to infer the normal function of a protein and to 
identify the cellular processes it is involved in. Th  e 
application of these approaches in mice has revealed a 
wealth of information on how the brain gets wired. Th  e 
converse question - how the brain can be miswired - has 
received less direct attention.
With the evidence of relevance to human disease, the 
phenotypes that arise in mice due to mutations in neuro-
developmental genes become of interest in themselves, 
not just as indicators of the normal function of the gene. 
It is important to ask: what happens to brain circuitry 
when a mutation aﬀ   ecting a process such as cell 
migration or synaptogenesis is mutated? Th  e primary 
defects due to impairment of that protein are just the 
start of the story. How does miswiring of the circuit aﬀ  ect 
its function? What are the secondary consequences of 
altered activity in developing circuits? How does the 
developing brain react to such changes? How does the 
ultimate anatomical outcome aﬀ  ect brain functions, as 
indexed by physiology and behavior? Answering these 
questions will be a major challenge for the future and will 
require an integration of expertise from diverse ﬁ  elds and 
disciplinary traditions [3].
Pathways and trajectories
One of the central questions emerging in the ﬁ  eld is how 
mutations in so many diﬀ  erent genes can yield similar 
clinical phenotypes. One possibility is that many of those 
genes’ products collaborate in speciﬁ   c pathways [4,5]. 
Comparison of the primary defects that arise across 
various mutants will help to group them into biochemical 
pathways controlling speciﬁ  c cellular processes. Muta-
tions in genes encoding proteins in the same pathways, 
may, in humans, be expected to give more similar clinical 
outcomes and possibly identify distinct subsets of 
patients [6].
An alternative, however, is that the phenotypic conver-
gence emerges secondarily, in how the brain responds to 
what may be a wide range of primary defects. Homeo  static 
processes that normally function to maintain circuit 
parameters within an optimal range may, in the context of 
an initially miswired network, become mal  adaptive and 
channel the network into a pathological state [7]. Th  e 
hypothesized emergence of psychosis due to maladaptive 
homeostasis in the dopaminergic pathway represents one 
possible example of such a phenomenon [8].
Gene discovery
Evolutionary genetic arguments suggest there must be a 
very large number of disease susceptibility loci to explain 
the prevalence of common, deleterious heritable 
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http://www.biomedcentral.com/1741-7007/9/23dis  orders [9]. Th  e loci so far implicated in psychiatric 
disorders in human patients collectively explain only a 
fraction of all cases, suggesting that a large number of 
susceptibility genes remain to be found. An important 
implication of the convergence of psychiatric genetics on 
neurodevelopmental genes is that other genes involved in 
neurodevelopment in mice become prime candidates to 
be these “missing genes”. If we can deﬁ  ne the phenotypic 
spectra and trajectories of known psychiatric disease 
mutations in mice, then it stands to reason that any other 
loci where mutations cause similar phenotypes in mice 
might result in a psychiatric disorder if mutated in 
humans.
Th   e size of the human population means that Murphy’s 
law can be applied to genomics: any gene that can be 
mutated, will be - in fact, already has been [10]. Whole-
genome sequencing approaches will provide catalogues 
of probably hundreds of mutations in each of us that 
deleteriously aﬀ  ect protein function [11]. Figuring out 
which of these is pathogenic in any given patient may be 
very diﬃ   cult, especially if mutations at any single locus 
are responsible for only a very small fraction of cases of 
any disorder. Statistical approaches based purely on the 
distribution of such mutations in human populations or 
their segregation in families will likely need to be 
supplemented with information from other sources in 
determining the overall evidence that any given mutation 
is pathogenic. Phenotypic comparisons in mice could 
thus provide a strong prior probability for the causal 
involvement of a speciﬁ  c mutation identiﬁ  ed in human 
patients.
Genetic architecture
Th   e phenotypic eﬀ  ects of any given mutation are likely to 
be modiﬁ  ed, perhaps strongly, by genetic background. 
Understanding such epistatic interactions may be crucial 
in explaining the imperfect segregation of mutations with 
mental illness in humans [1]. Whether these interactions 
can proﬁ   tably be explored in mice remains an open 
question. While genetic background eﬀ  ects are common 
for neurodevelopmental and especially behavioral pheno-
types, there is no reason to think that the particular 
background eﬀ  ects in inbred lines of mice have direct 
relevance to human populations. On the other hand, the 
analysis of mice carrying mutations in several genes can 
be highly informative as to whether they function in 
similar pathways and how the system responds to 
multiple hits. Expanding genetic analyses of neuro-
develop  ment to explore those kinds of epistatic inter-
actions will therefore likely shed additional light on 
genetic complexities of these disorders in humans.
Th   is is an exciting time, as a new ﬁ  eld emerges at the 
overlap of developmental neurobiology and psychiatric 
genetics. Th  e initial discoveries in both humans and 
animals provide crucial entry points to explore - using 
the full arsenal of molecular, cellular and systems 
neuroscience approaches - how mutations in neuro-
developmental genes impact on neural circuit structure 
and function, ultimately resulting in psychopathology.
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